Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Cardiovasc Drugs Ther. 2021 Aug;35(4):875-876. doi: 10.1007/s10557-021-07165-3. Epub 2021 Mar 4.

Authors

Patrick Sulzgruber¹, Felix Hofer², Niema Kazem², Andreas Hammer², Alexander Niessner²

Affiliations

¹ Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. [email protected].
² Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

PMID: 33661431
DOI: 10.1007/s10557-021-07165-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Atrial Fibrillation* / complications
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / therapy
Hemorrhage / chemically induced
Hemorrhage / diagnosis
Hemorrhage / epidemiology
Humans
Percutaneous Coronary Intervention* / adverse effects